Changing the Paradigm in Prognostic Breast Cancer Testing Based on Extracellular Vesicles
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Guinney J, Dienstmann R, Wang X, De Reynies A, Schlicker A, Soneson C
. The consensus molecular subtypes of colorectal cancer. Nat Med. 2015; 21(11):1350-6.
PMC: 4636487.
DOI: 10.1038/nm.3967.
View
2.
Prat A, Parker J, Fan C, Perou C
. PAM50 assay and the three-gene model for identifying the major and clinically relevant molecular subtypes of breast cancer. Breast Cancer Res Treat. 2012; 135(1):301-6.
PMC: 3413822.
DOI: 10.1007/s10549-012-2143-0.
View
3.
Kamoun A, De Reynies A, Allory Y, Sjodahl G, Robertson A, Seiler R
. A Consensus Molecular Classification of Muscle-invasive Bladder Cancer. Eur Urol. 2019; 77(4):420-433.
PMC: 7690647.
DOI: 10.1016/j.eururo.2019.09.006.
View
4.
Yin L, Duan J, Bian X, Yu S
. Triple-negative breast cancer molecular subtyping and treatment progress. Breast Cancer Res. 2020; 22(1):61.
PMC: 7285581.
DOI: 10.1186/s13058-020-01296-5.
View
5.
Hu M, Brown V, M Jackson J, Wijerathne H, Pathak H, Koestler D
. Assessing Breast Cancer Molecular Subtypes Using Extracellular Vesicles' mRNA. Anal Chem. 2023; 95(19):7665-7675.
PMC: 10243595.
DOI: 10.1021/acs.analchem.3c00624.
View